H-Ventures Group
H-Ventures Group is a Milan-headquartered, privately-held Italian innovation company operating at the intersection of pharmaceutical logistics and AI-enabled life sciences, serving pharmaceutical manufacturers, hospital and pharmacy networks, and companies pursuing transatlantic expansion through consulting, managed logistics, and data platforms.
- Company typePrivate
- Founded-
- HeadquartersMilan, Italy
- Headcount101–250
- GTM typeB2B
- OfferingServices
What H-Ventures Group does
H-Ventures Group is a privately-held Italian innovation company headquartered in Milan, with additional offices in Pavia, Rome, and New York. It operates at the intersection of pharmaceutical distribution and AI-enabled life sciences, organized as a group with wholly-owned H-Ventures Solutions, a 50%-owned H-Ventures US subsidiary, and minority stakes in Atlas and MIND Reply. The firm reports four decades of operational heritage in pharma logistics alongside newer digital-health and data-engineering capabilities.
The company's offering spans five core areas: Pharma Logistics & Distribution (cold-chain management, serialization, warehouse automation, hospital and home-care delivery); AI, Data Intelligence & Digital Health (predictive analytics, patient-journey modeling, real-world evidence, digital therapeutics, cognitive vision and wearables); Innovation & Venture Acceleration via H-Ventures US; Academic Excellence & Advanced Data Engagement (university-validated analytical models in partnership with the University of Pavia); and Market Intelligence, Business Design & Global Expansion supporting transatlantic market entry. The portfolio is complemented by a Solutions division covering pharmacy retail performance, commercial and field-activation marketing, pharmaceutical market launch, communication and e-commerce, and training programs, plus MIND Reply sub-brands for SaaS, cloud infrastructure, cybersecurity, and managed IT.
H-Ventures generates revenue through a mix of professional-services engagements (consulting, market intelligence, market launch, and retail-performance projects), managed logistics services for pharma manufacturers and pharmacy networks, and subscription/recurring platform revenue from AI and data-intelligence deployments. Pricing is quote-based and not publicly disclosed. The company sells directly to enterprise customers across Italy, Europe, and the United States, with go-to-market concentrated in pharmaceutical manufacturers and distributors, hospital networks, pharmacy chains, life-sciences organizations, and companies undertaking cross-border expansion. Leadership is anchored by founder and CEO Alfredo Sassi, who also serves as Contract Professor at the University of Pavia, Vice President of LIPHE, and Honorary Consul of the Republic of Latvia in Lombardy.
H-Ventures Group firmographics
Firmographics- Name
- H-Ventures Group
- Legal name
- H-Ventures Solutions S.r.l.
- Website
- https://h-venturessrl.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- H-Ventures Group is a Milan-headquartered, privately-held Italian innovation company operating at the intersection of pharmaceutical logistics and AI-enabled life sciences, serving pharmaceutical manufacturers, hospital and pharmacy networks, and companies pursuing transatlantic expansion through consulting, managed logistics, and data platforms.
- Ownership category
- akta.pro rank
H-Ventures Group industry classification
Industry- Product category
- Pharmaceutical & Healthcare Consulting Services
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Health and Welfare Funds (525120)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- HR Technology (HRIS/HCM) Advisory & Implementation (BPAHAGAG)
Keywords
Where H-Ventures Group is headquartered
LocationHeadquarters
- HQ city
- Milan
- HQ country
- Italy
- HQ region
- Europe
Offices4 records
Markets served
H-Ventures Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharma Logistics & Distribution: Integrated logistic services including cold-chain management, serialization, warehouse automation, and hospital/home-care delivery for pharmaceutical manufacturers, hospitals, and pharmacy networks. Combines physical logistics operations with digital platforms for full traceability.
- AI, Data Intelligence & Digital Health Solutions: AI-driven platforms, predictive analytics, digital therapeutics, and data warehousing services for healthcare organizations. Revenue generated through platform development, implementation, and ongoing support.
- Commercial & Marketing Services: Category management, merchandising, mystery shopping, customer satisfaction surveys, CRM initiatives, and field activation programs for pharmacies and pharmaceutical industries.
- Pharmaceutical Market Launch & NPI: New product introduction services including market sizing, segmentation, positioning strategy, regulatory alignment, and omni-channel go-to-market execution for pharmaceutical companies entering Italian market.
- Pharmacy Management & Retail Performance Consulting: End-to-end consulting including due diligence, geomarketing analysis, ERP optimization, business intelligence, strategic planning, and KPI monitoring.
- Market Intelligence & Global Expansion: Market research, competitive intelligence, operational business plans, and cross-border go-to-market consulting supporting companies entering new markets in Italy/Europe and the United States.
- Innovation & Venture Acceleration (H-Ventures US): Gateway services for U.S. innovation, supporting Italian companies with soft-landing programs, U.S. market entry, and transatlantic positioning.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
H-Ventures Group product offering
Product offeringCore offering
H-Ventures Group is an international innovation company that delivers integrated consulting, technology, and operational services to pharmaceutical manufacturers, hospital networks, pharmacy chains, and healthcare organizations. Its portfolio combines pharma logistics and distribution (cold-chain, serialization, warehouse automation, hospital and home-care delivery) with AI-driven digital health platforms (predictive analytics, digital therapeutics, data warehousing), cross-border market entry support via H-Ventures US, and university-validated data engagement models.
Product overview
H-Ventures Group operates as a diversified innovation company with five core business areas: Pharma Logistics & Distribution Ecosystem, AI/Data Intelligence & Digital Health, H-Ventures US (Innovation & Venture Acceleration), Academic Excellence & Advanced Data Engagement, and Market Intelligence & Global Expansion. The portfolio also includes a Solutions division offering Pharmaceutical Distribution & PaaS, Digital Health/IT/Data Platforms, Commercial/In-Store/Shopper Marketing, Pharmaceutical Market Launch & NPI, Pharmacy Management & Retail Performance, Communication/Social Media/E-Commerce, and People/Training/Special Projects. The group also includes MIND Reply as a subsidiary (50%) providing Software Development & SaaS Solutions, Infrastructure & Cloud, Cybersecurity, and Managed IT Services.
Differentiator
Problem solved
Functional benefit
Brands
- MIND Reply: Ecosystem of IT companies focused on technological innovation, software development, cloud infrastructure, cybersecurity, and managed IT services for logistics, pharmaceutical, marine, insurance, and professional services industries.
Products and services
- Pharma Logistics & Distribution Ecosystem Integrated logistic systems for pharmaceutical manufacturers, hospital networks, and pharmacy chains, including cold-chain management, serialization, labeling, repackaging, automation and robotics for smart warehouses, hospital and home-care logistics, and pharmacy retail network development.
- AI, Data Intelligence & Digital Health AI-driven platforms and solutions for healthcare organizations that convert complex health data into actionable insight, predictive analytics, patient-journey modeling, real-world evidence, digital therapeutics, cognitive vision, and wearable-enabled engagement systems.
- H-Ventures US (Innovation & Venture Acceleration) U.S. innovation gateway providing market entry support, soft-landing programs, and strategic transatlantic positioning for Italian and European companies expanding to the United States.
- Academic Excellence & Advanced Data Engagement State-of-the-art data engagement models integrating academic rigor with industry execution, powered by university-validated analytical methodologies and AI-driven patient and customer engagement tools.
- Market Intelligence, Business Design & Global Expansion Advanced market research, operational business plans, financial modeling, and cross-border go-to-market programs enabling companies to enter new markets and scale effectively in Italy/Europe and the United States.
- Pharmaceutical Distribution & PaaS Redesigned distribution models with integrated logistic platforms, cold-chain management, warehouse automation, reverse logistics, hospital and home-care delivery, and project-financing initiatives for pharmaceutical manufacturers and healthcare providers.
- Digital Health, IT & Data Platforms Digital ecosystems for health and retail including digital health and digital therapeutics projects, AI and machine-learning platforms, data warehouses, web and mobile applications, SaaS solutions, and wearable-enabled patient journeys.
- Commercial, In-Store & Shopper Marketing Commercial and field-activation programs for pharmacies and pharmaceutical industries, including category management, merchandising, mystery shopping, customer satisfaction surveys, assortment analysis, price tracking, and advanced CRM initiatives.
- Pharmaceutical Market Launch & New Product Introduction Evidence-based market entry frameworks for launching pharmaceutical companies and product lines, including market sizing, segmentation, positioning strategy, regulatory alignment, and omni-channel go-to-market execution.
- Pharmacy Management & Retail Performance End-to-end pharmacy consulting including due diligence, geomarketing, catchment area analysis, ERP optimization, business intelligence, strategic plans, KPI monitoring, and funding support for pharmacies and pharmacy chains.
- Communication, Social Media & E-Commerce Integrated communication ecosystems for pharmacies and pharmaceutical brands, including brand growth strategies, social media marketing, loyalty systems, corporate communication, e-commerce platforms, and web-scraping analyses.
- People, Training & Special Projects Human-capital and training programs including organizational assessments, role design, team building, incentive schemes, and multi-format training programs, plus trade-marketing initiatives and patient-care projects for pharmaceutical and healthcare clients.
- MIND Reply - Software Development & SaaS Solutions Scalable software architectures and cloud-native SaaS platforms designed to optimize processes and generate recurring value for logistics, pharmaceutical, marine, insurance, and professional services industries. Delivered through the MIND Reply subsidiary ecosystem.
- MIND Reply - Infrastructure & Cloud Cloud migration guidance and hybrid systems management providing solid, secure, and flexible technology foundations for regulated and mission-critical industries including logistics, pharmaceutical, marine, and insurance.
- MIND Reply - Cybersecurity Advanced security protocols, continuous monitoring, and proactive defense strategies protecting data assets for compliance-driven and mission-critical industry operations across logistics, pharmaceutical, marine, and insurance sectors.
- MIND Reply - Managed IT Services Ongoing technical support and consulting ensuring technology remains a growth driver, with capabilities spanning logistics, pharmaceutical, marine, insurance, and professional services sectors.
Quantifiable outcome
- Faster access to therapies and optimized care pathways through intelligent supply chains
- +3 more outcomes
Companies that use H-Ventures Group
Customer profileSegments5 records
Ideal customer profiles5 records
H-Ventures Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature13 records
H-Ventures Group partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- LIPHE (Logistica Integrata Pharma Healthcare)coreH-Ventures actively leads LIPHE, contributing to shaping the national framework for healthcare logistics, digital transformation, and regulatory innovation in the pharmaceutical supply chain. CEO Alfredo Sassi serves as Vice President of LIPHE and Coordinator of the LIPHE Innovation Lab at MIND.
- AFI (Italian Pharmaceutical Industries Association)coreH-Ventures shares expertise and dialogue with Italy's main network of pharmaceutical manufacturers, supporting innovation policies and joint projects in drug distribution, R&D, and digital health.
- American Chamber of Commerce in Italy (AMCHAM)coreH-Ventures is a Sustaining Member of AMCHAM, strengthening the transatlantic bridge between Italy and the United States and promoting ethical business growth, international trade, and technological collaboration.
- Federated Innovation @ MINDcoreH-Ventures is a Founder Member and Innovation Partner of Federated Innovation @ MIND, Italy's leading innovation district. The company co-leads the RetailTech Thematic Area and collaborates on Life Sciences projects, fostering open innovation between research, industry, and institutions.
- University of PaviacoreAcademic partnership where CEO Alfredo Sassi serves as Contract Professor of Big Data & Computational Models for Marketing at the Master's Degree in Digital Communication, enabling continuous knowledge transfer between research and market execution.
- Università Cattolica del Sacro CuoreminorUniversity agreement for academic collaboration and knowledge sharing in research and education initiatives.
- AXA XLminorAXA XL provides non-conditional contribution to the LIPHE Innovation Lab initiative, demonstrating corporate sponsorship of healthcare logistics innovation projects.
- Mind ReplycoreSubsidiary (50% owned) operating as an ecosystem of IT companies accelerating digital transformation through integration of specialized expertise in software development, infrastructure/cloud, cybersecurity, and managed IT services for logistics, pharmaceutical, marine, insurance, and professional services industries.
- H-Ventures SolutionscoreSubsidiary (100% owned) providing integrated solutions across pharma logistics, digital health, commercial services, and market intelligence.
- H-Ventures UScoreSubsidiary (50% owned) serving as the gateway to U.S. innovation, supporting market entry and transatlantic expansion for European companies.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
H-Ventures Group competitors and assessment
Company assessmentDirect peers
- Syneos Health: Contract research and commercialization organization providing pharma market launch, NPI, and field activation services. Directly comparable to H-Ventures' Pharmaceutical Market Launch & NPI, Commercial & Marketing Services, and cross-border go-to-market programs targeting pharma manufacturers.
- Putnam Associates: Specialized life sciences strategy consulting firm focused on pharmaceutical market access, launch strategy, and commercial insights. Comparable in size, focus, and buyer to H-Ventures' pharmaceutical market launch, market intelligence, and global expansion advisory work.
- Charles River Associates: Global consulting firm with a Life Sciences practice focused on pharmaceutical strategy, market access, and commercial due diligence. Comparable to H-Ventures' pharma strategy and market launch consulting offerings, with deeper US/UK presence.
- Reply Group: Italian-listed IT services and digital transformation group with deep operations in Italy and offices across Europe. Directly comparable to H-Ventures Group because H-Ventures' 50%-owned subsidiary MIND Reply operates within the Reply-style model of specialized IT boutiques serving logistics, pharma, insurance, and professional services — making Reply the closest publicly traded mirror of the H-Ventures/MIND Reply group structure.
Broad incumbents
- UPS Healthcare: Division of UPS specializing in pharmaceutical logistics, cold-chain, and clinical trial supply. Comparable to H-Ventures' integrated logistics and hospital/home-care delivery capabilities, with significantly larger global footprint.
- Accenture (Life Sciences): Global management consulting and technology services firm with a dedicated Life Sciences practice covering pharma supply chain, digital health, and market entry. Comparable to H-Ventures' consulting-plus-technology delivery model, though operating at global scale across the same buyer set.
- DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics provider with a dedicated Life Sciences & Healthcare vertical covering cold-chain, serialization, and warehouse automation. Comparable to H-Ventures' Pharma Logistics & Distribution Ecosystem offering, though at vastly larger infrastructure and geographic scale.
- IQVIA: Global leader in life sciences analytics, technology, and contract services, with a substantial pharmaceutical market access, market launch, and real-world evidence practice. Comparable to H-Ventures' AI/Data Intelligence & Digital Health and Market Intelligence & Global Expansion offerings, though at vastly larger scale and global reach.
- Deloitte (Life Sciences & Health Care): Big Four advisory firm with substantial healthcare and life sciences consulting, including pharma supply chain, market access, and digital transformation practices. Comparable to H-Ventures' integrated consulting offering for pharma and healthcare clients, but with global delivery.
Emerging players
- Alira Health: Mid-sized global life sciences and healthcare consulting firm with practices spanning pharma market access, real-world evidence, digital health, and patient engagement. Comparable in size and scope to H-Ventures' AI/Data Intelligence & Digital Health and Market Intelligence & Global Expansion offerings, with stronger US presence.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
H-Ventures Group social profiles
Digital presenceH-Ventures Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
H-Ventures Group leadership team
Management profileNumber of profiles
Profiles2 records
H-Ventures Group subsidiaries and ownership
Company hierarchySubsidiaries4 records
H-Ventures Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
H-Ventures Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about H-Ventures Group
What does H-Ventures Group do?
H-Ventures Group is an international innovation company that delivers integrated consulting, technology, and operational services to pharmaceutical manufacturers, hospital networks, pharmacy chains, and healthcare organizations. Its portfolio combines pharma logistics and distribution (cold-chain, serialization, warehouse automation, hospital and home-care delivery) with AI-driven digital health platforms (predictive analytics, digital therapeutics, data warehousing), cross-border market entry support via H-Ventures US, and university-validated data engagement models.
Is H-Ventures Group a public or private company?
H-Ventures Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was H-Ventures Group founded?
H-Ventures Group was founded in -1. It employs 101 to 250 people.
Where is H-Ventures Group based?
H-Ventures Group is headquartered in Milan, Italy, in the Europe region.
How does H-Ventures Group make money?
Seven revenue lines are on record. Pharma Logistics & Distribution is the primary driver. The others are AI, Data Intelligence & Digital Health Solutions, commercial & Marketing Services, pharmaceutical Market Launch & NPI, pharmacy Management & Retail Performance Consulting, market Intelligence & Global Expansion and innovation & Venture Acceleration (H-Ventures US).
Who are H-Ventures Group's main competitors?
Direct peers on record are Syneos Health, Putnam Associates, Charles River Associates and Reply Group. Broad incumbents are UPS Healthcare, Accenture (Life Sciences), DHL Supply Chain (Life Sciences & Healthcare), IQVIA and Deloitte (Life Sciences & Health Care). Alira Health is listed as an emerging player.
Does H-Ventures Group have an API?
No public API is recorded for H-Ventures Group.
What industry is H-Ventures Group in?
H-Ventures Group's product category is Pharmaceutical & Healthcare Consulting Services. Its primary akta.pro industry code is BPAHAGAG, HR Technology (HRIS/HCM) Advisory & Implementation. Its NAICS code is 524292 and its SIC code is 8742.